| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
| Endotoxemia | 2 | 2018 | 143 | 1.30 | Why? |
| Extracorporeal Membrane Oxygenation | 12 | 2021 | 5002 | 1.28 | Why? |
| Transcatheter Aortic Valve Replacement | 3 | 2018 | 839 | 1.12 | Why? |
| Fluid Therapy | 4 | 2019 | 628 | 0.90 | Why? |
| Resuscitation | 5 | 2019 | 638 | 0.89 | Why? |
| Heart-Assist Devices | 6 | 2018 | 812 | 0.84 | Why? |
| Cannula | 3 | 2020 | 750 | 0.81 | Why? |
| Hemodynamics | 8 | 2019 | 1562 | 0.78 | Why? |
| Aortic Valve Stenosis | 2 | 2017 | 741 | 0.76 | Why? |
| Phosphopyruvate Hydratase | 1 | 2018 | 47 | 0.75 | Why? |
| Sheep | 6 | 2018 | 420 | 0.75 | Why? |
| Heart-Lung Machine | 1 | 2017 | 3 | 0.73 | Why? |
| Queensland | 5 | 2018 | 188 | 0.71 | Why? |
| Kidneys, Artificial | 1 | 2017 | 37 | 0.69 | Why? |
| Matrix Metalloproteinase 9 | 1 | 2018 | 211 | 0.68 | Why? |
| Brain Infarction | 1 | 2018 | 129 | 0.67 | Why? |
| Oxygen Inhalation Therapy | 3 | 2020 | 3629 | 0.67 | Why? |
| Ventricular Dysfunction | 1 | 2018 | 150 | 0.65 | Why? |
| Blood Preservation | 1 | 2018 | 191 | 0.65 | Why? |
| Spectroscopy, Near-Infrared | 1 | 2017 | 137 | 0.63 | Why? |
| Hemofiltration | 1 | 2017 | 155 | 0.60 | Why? |
| Intraoperative Complications | 1 | 2017 | 221 | 0.59 | Why? |
| Capacity Building | 1 | 2021 | 683 | 0.58 | Why? |
| Coronary Artery Bypass | 2 | 2018 | 629 | 0.57 | Why? |
| Cerebral Infarction | 1 | 2017 | 245 | 0.56 | Why? |
| Myocardial Ischemia | 2 | 2018 | 781 | 0.55 | Why? |
| Erythrocyte Transfusion | 1 | 2018 | 386 | 0.54 | Why? |
| Endocardium | 1 | 2014 | 90 | 0.54 | Why? |
| Hemostasis | 2 | 2017 | 811 | 0.53 | Why? |
| Fluorocarbons | 1 | 2014 | 102 | 0.51 | Why? |
| Erythrocytes | 2 | 2018 | 617 | 0.50 | Why? |
| Postoperative Care | 1 | 2018 | 755 | 0.49 | Why? |
| Image Enhancement | 1 | 2014 | 177 | 0.49 | Why? |
| Postoperative Complications | 5 | 2018 | 5861 | 0.48 | Why? |
| Cognition Disorders | 1 | 2017 | 574 | 0.46 | Why? |
| Ventilator Weaning | 1 | 2017 | 536 | 0.46 | Why? |
| Microdialysis | 1 | 2010 | 22 | 0.44 | Why? |
| Pressure Ulcer | 1 | 2017 | 398 | 0.44 | Why? |
| Vasoconstrictor Agents | 4 | 2019 | 714 | 0.44 | Why? |
| Critical Illness | 6 | 2021 | 17281 | 0.44 | Why? |
| Shock | 1 | 2018 | 1868 | 0.43 | Why? |
| Antipsychotic Agents | 1 | 2019 | 887 | 0.42 | Why? |
| Decision Support Techniques | 1 | 2018 | 903 | 0.42 | Why? |
| Acute Lung Injury | 1 | 2018 | 904 | 0.41 | Why? |
| Models, Cardiovascular | 4 | 2018 | 153 | 0.40 | Why? |
| Chest Tubes | 1 | 2010 | 177 | 0.38 | Why? |
| Sepsis | 4 | 2019 | 3517 | 0.38 | Why? |
| Chromatography, Liquid | 3 | 2018 | 640 | 0.37 | Why? |
| Respiration, Artificial | 7 | 2021 | 22116 | 0.37 | Why? |
| Australia | 9 | 2019 | 6306 | 0.36 | Why? |
| Delirium | 1 | 2018 | 1061 | 0.34 | Why? |
| International Cooperation | 1 | 2021 | 3436 | 0.34 | Why? |
| Bariatric Surgery | 1 | 2018 | 1298 | 0.34 | Why? |
| Cytochrome P-450 Enzyme System | 2 | 2018 | 144 | 0.33 | Why? |
| Inflammation Mediators | 1 | 2018 | 2654 | 0.33 | Why? |
| Tissue and Organ Procurement | 1 | 2018 | 1277 | 0.33 | Why? |
| Critical Care | 6 | 2021 | 14081 | 0.32 | Why? |
| Patient Selection | 2 | 2020 | 4560 | 0.32 | Why? |
| Laparoscopy | 1 | 2018 | 1532 | 0.32 | Why? |
| Heart Ventricles | 2 | 2017 | 1139 | 0.32 | Why? |
| Hemostatics | 2 | 2017 | 142 | 0.30 | Why? |
| Drug Delivery Systems | 1 | 2014 | 1365 | 0.28 | Why? |
| Hypotension | 2 | 2018 | 392 | 0.28 | Why? |
| Lung Diseases | 1 | 2018 | 2361 | 0.28 | Why? |
| Tomography | 2 | 2017 | 183 | 0.26 | Why? |
| Tracheostomy | 1 | 2017 | 1963 | 0.26 | Why? |
| Tandem Mass Spectrometry | 3 | 2018 | 1031 | 0.25 | Why? |
| Pneumonia, Bacterial | 1 | 2010 | 843 | 0.25 | Why? |
| Pneumothorax | 1 | 2010 | 758 | 0.23 | Why? |
| Intensive Care Units | 8 | 2021 | 29594 | 0.23 | Why? |
| Brain Ischemia | 1 | 2017 | 2813 | 0.23 | Why? |
| Global Health | 3 | 2021 | 13911 | 0.22 | Why? |
| Fibrinogen | 2 | 2017 | 1048 | 0.22 | Why? |
| Mortality | 1 | 2018 | 7132 | 0.22 | Why? |
| Biomedical Research | 1 | 2021 | 5270 | 0.21 | Why? |
| Respiratory Function Tests | 2 | 2018 | 1755 | 0.21 | Why? |
| Brain | 1 | 2017 | 5133 | 0.21 | Why? |
| Echocardiography | 1 | 2014 | 3661 | 0.20 | Why? |
| Lung Compliance | 1 | 2021 | 243 | 0.20 | Why? |
| Humans | 54 | 2021 | 930598 | 0.19 | Why? |
| Erythrocyte Deformability | 1 | 2018 | 15 | 0.19 | Why? |
| Tobramycin | 1 | 2018 | 18 | 0.19 | Why? |
| S100 Calcium Binding Protein beta Subunit | 1 | 2018 | 63 | 0.19 | Why? |
| Glial Fibrillary Acidic Protein | 1 | 2018 | 138 | 0.18 | Why? |
| Anti-Bacterial Agents | 5 | 2019 | 10083 | 0.18 | Why? |
| Embolic Protection Devices | 1 | 2017 | 16 | 0.18 | Why? |
| Rheology | 1 | 2018 | 70 | 0.18 | Why? |
| Stress, Mechanical | 1 | 2018 | 143 | 0.18 | Why? |
| Cardiovascular Physiological Phenomena | 1 | 2018 | 70 | 0.18 | Why? |
| Vascular Grafting | 1 | 2017 | 23 | 0.18 | Why? |
| Pulsatile Flow | 1 | 2018 | 123 | 0.18 | Why? |
| Shock, Septic | 2 | 2018 | 1313 | 0.18 | Why? |
| Lung | 3 | 2018 | 31049 | 0.17 | Why? |
| Larynx, Artificial | 1 | 2017 | 27 | 0.17 | Why? |
| Intracranial Hemorrhage, Traumatic | 1 | 2016 | 6 | 0.17 | Why? |
| Solid Phase Extraction | 2 | 2017 | 23 | 0.17 | Why? |
| Advanced Cardiac Life Support | 1 | 2017 | 75 | 0.17 | Why? |
| Enzyme Assays | 1 | 2018 | 295 | 0.17 | Why? |
| Isotonic Solutions | 1 | 2017 | 69 | 0.17 | Why? |
| Obesity | 1 | 2018 | 7388 | 0.17 | Why? |
| Disease Transmission, Infectious | 1 | 2020 | 9044 | 0.17 | Why? |
| Electric Impedance | 2 | 2017 | 283 | 0.17 | Why? |
| Hemostatic Techniques | 1 | 2017 | 60 | 0.17 | Why? |
| Intracranial Embolism | 1 | 2017 | 73 | 0.16 | Why? |
| Pneumonia | 1 | 2017 | 5652 | 0.16 | Why? |
| Ciprofloxacin | 1 | 2017 | 130 | 0.16 | Why? |
| Health Services, Indigenous | 1 | 2018 | 178 | 0.16 | Why? |
| Cardiopulmonary Bypass | 1 | 2017 | 158 | 0.16 | Why? |
| Diagnosis-Related Groups | 1 | 2017 | 167 | 0.16 | Why? |
| Posture | 1 | 2018 | 199 | 0.16 | Why? |
| Diffusion Magnetic Resonance Imaging | 1 | 2018 | 317 | 0.16 | Why? |
| Nurse-Patient Relations | 1 | 2018 | 168 | 0.16 | Why? |
| Monitoring, Intraoperative | 1 | 2017 | 140 | 0.16 | Why? |
| Preliminary Data | 1 | 2018 | 457 | 0.15 | Why? |
| Intubation, Intratracheal | 2 | 2018 | 3962 | 0.15 | Why? |
| Cold Temperature | 1 | 2017 | 260 | 0.15 | Why? |
| Dexmedetomidine | 1 | 2017 | 130 | 0.15 | Why? |
| Linear Models | 3 | 2017 | 1914 | 0.15 | Why? |
| Observational Studies as Topic | 2 | 2020 | 1887 | 0.15 | Why? |
| Female | 21 | 2021 | 380317 | 0.15 | Why? |
| Odds Ratio | 2 | 2018 | 5861 | 0.15 | Why? |
| Platelet Aggregation | 1 | 2017 | 318 | 0.14 | Why? |
| Factor VIII | 1 | 2017 | 229 | 0.14 | Why? |
| Analgesics | 1 | 2019 | 451 | 0.14 | Why? |
| Attention | 1 | 2018 | 335 | 0.14 | Why? |
| Hemorrhage | 2 | 2017 | 3013 | 0.14 | Why? |
| Morbidity | 2 | 2018 | 1426 | 0.14 | Why? |
| Death | 1 | 2018 | 334 | 0.14 | Why? |
| Hemolysis | 1 | 2017 | 283 | 0.14 | Why? |
| Compassion Fatigue | 1 | 2018 | 228 | 0.14 | Why? |
| Craniocerebral Trauma | 1 | 2016 | 160 | 0.14 | Why? |
| Wounds and Injuries | 2 | 2017 | 1708 | 0.14 | Why? |
| Feasibility Studies | 4 | 2018 | 3467 | 0.14 | Why? |
| Time Factors | 7 | 2019 | 31397 | 0.14 | Why? |
| Pilot Projects | 4 | 2018 | 5182 | 0.13 | Why? |
| Catheters | 1 | 2014 | 93 | 0.13 | Why? |
| Cerebrovascular Circulation | 1 | 2017 | 340 | 0.13 | Why? |
| Tidal Volume | 1 | 2017 | 565 | 0.13 | Why? |
| Lipopolysaccharides | 1 | 2018 | 848 | 0.13 | Why? |
| Protective Clothing | 1 | 2017 | 468 | 0.13 | Why? |
| Anesthesia, General | 1 | 2018 | 470 | 0.13 | Why? |
| Hypnotics and Sedatives | 1 | 2019 | 624 | 0.13 | Why? |
| Bronchiolitis | 1 | 2018 | 297 | 0.13 | Why? |
| Animals | 9 | 2018 | 78931 | 0.13 | Why? |
| Aged, 80 and over | 6 | 2018 | 88759 | 0.13 | Why? |
| Male | 19 | 2021 | 367725 | 0.13 | Why? |
| Awareness | 1 | 2018 | 529 | 0.12 | Why? |
| Microspheres | 1 | 2014 | 261 | 0.12 | Why? |
| Heart Failure | 4 | 2017 | 6638 | 0.12 | Why? |
| Disease Outbreaks | 2 | 2021 | 27595 | 0.12 | Why? |
| Life Expectancy | 1 | 2018 | 474 | 0.12 | Why? |
| Aged | 12 | 2021 | 215776 | 0.12 | Why? |
| Magnetic Resonance Imaging, Cine | 1 | 2017 | 669 | 0.12 | Why? |
| Reproducibility of Results | 4 | 2018 | 11304 | 0.12 | Why? |
| Oxygen Consumption | 1 | 2017 | 711 | 0.12 | Why? |
| Oximetry | 1 | 2017 | 658 | 0.12 | Why? |
| Morphine | 1 | 2012 | 71 | 0.12 | Why? |
| Healthy Volunteers | 1 | 2018 | 1444 | 0.12 | Why? |
| Midazolam | 1 | 2012 | 79 | 0.12 | Why? |
| Blood Coagulation Tests | 1 | 2017 | 855 | 0.12 | Why? |
| Gases | 1 | 2012 | 113 | 0.11 | Why? |
| Respiration | 1 | 2017 | 729 | 0.11 | Why? |
| Surveys and Questionnaires | 2 | 2020 | 43792 | 0.11 | Why? |
| Prospective Studies | 5 | 2021 | 43301 | 0.11 | Why? |
| Pulmonary Ventilation | 1 | 2012 | 152 | 0.11 | Why? |
| Fentanyl | 1 | 2012 | 142 | 0.11 | Why? |
| Shock, Cardiogenic | 1 | 2017 | 700 | 0.10 | Why? |
| Program Development | 1 | 2017 | 1089 | 0.10 | Why? |
| Preoperative Care | 2 | 2017 | 1515 | 0.10 | Why? |
| Asia | 1 | 2017 | 2399 | 0.10 | Why? |
| Nanostructures | 1 | 2017 | 700 | 0.10 | Why? |
| Pleural Diseases | 1 | 2010 | 68 | 0.10 | Why? |
| Cardiac Catheterization | 1 | 2017 | 882 | 0.10 | Why? |
| Resource Allocation | 1 | 2021 | 1771 | 0.10 | Why? |
| Bronchoalveolar Lavage Fluid | 1 | 2018 | 2309 | 0.10 | Why? |
| Blood Pressure | 2 | 2018 | 2198 | 0.10 | Why? |
| Hospitalization | 2 | 2017 | 54280 | 0.10 | Why? |
| Positive-Pressure Respiration | 1 | 2017 | 1160 | 0.09 | Why? |
| Middle Aged | 11 | 2021 | 270681 | 0.09 | Why? |
| Heart | 1 | 2018 | 1791 | 0.09 | Why? |
| Contrast Media | 1 | 2014 | 1011 | 0.09 | Why? |
| Adult | 10 | 2021 | 244371 | 0.09 | Why? |
| Emergency Service, Hospital | 5 | 2019 | 14232 | 0.09 | Why? |
| Noninvasive Ventilation | 1 | 2020 | 2329 | 0.08 | Why? |
| South Africa | 1 | 2017 | 3326 | 0.08 | Why? |
| Oxygen | 1 | 2020 | 3715 | 0.08 | Why? |
| Biomarkers | 3 | 2018 | 23361 | 0.08 | Why? |
| Treatment Outcome | 6 | 2018 | 51732 | 0.08 | Why? |
| Stroke | 2 | 2021 | 8839 | 0.08 | Why? |
| Telemedicine | 1 | 2018 | 25032 | 0.08 | Why? |
| Heart Transplantation | 1 | 2017 | 1293 | 0.08 | Why? |
| Health Care Rationing | 1 | 2021 | 2558 | 0.08 | Why? |
| Survival Rate | 2 | 2018 | 9206 | 0.08 | Why? |
| Retrospective Studies | 6 | 2021 | 105322 | 0.08 | Why? |
| Risk Factors | 4 | 2021 | 71621 | 0.08 | Why? |
| Ventilators, Mechanical | 1 | 2018 | 2193 | 0.07 | Why? |
| Myocardial Infarction | 2 | 2018 | 3361 | 0.07 | Why? |
| Nursing Staff, Hospital | 1 | 2018 | 1554 | 0.07 | Why? |
| Cardiac Surgical Procedures | 1 | 2017 | 1931 | 0.07 | Why? |
| Risk Assessment | 2 | 2018 | 25439 | 0.06 | Why? |
| Magnetic Resonance Imaging | 2 | 2017 | 6551 | 0.06 | Why? |
| Predictive Value of Tests | 1 | 2018 | 9537 | 0.06 | Why? |
| Length of Stay | 2 | 2018 | 11042 | 0.06 | Why? |
| Equipment Design | 3 | 2018 | 3095 | 0.06 | Why? |
| Pandemics | 7 | 2021 | 389249 | 0.05 | Why? |
| Referral and Consultation | 1 | 2017 | 4816 | 0.05 | Why? |
| Hospital Mortality | 3 | 2021 | 22087 | 0.05 | Why? |
| Registries | 1 | 2020 | 12327 | 0.05 | Why? |
| Disease Models, Animal | 1 | 2018 | 10998 | 0.05 | Why? |
| Pharmaceutical Preparations | 1 | 2014 | 1897 | 0.05 | Why? |
| Case-Control Studies | 1 | 2018 | 17671 | 0.05 | Why? |
| Sensitivity and Specificity | 3 | 2017 | 22971 | 0.05 | Why? |
| Cytochrome P-450 CYP2C9 | 1 | 2018 | 25 | 0.05 | Why? |
| Cytochrome P-450 CYP2C19 | 1 | 2018 | 25 | 0.05 | Why? |
| Cytochrome P-450 CYP2D6 | 1 | 2018 | 28 | 0.05 | Why? |
| Randomized Controlled Trials as Topic | 1 | 2018 | 10649 | 0.05 | Why? |
| Pragmatic Clinical Trials as Topic | 1 | 2020 | 350 | 0.05 | Why? |
| Cardiovascular Nursing | 1 | 2018 | 33 | 0.05 | Why? |
| Clinical Trials as Topic | 1 | 2018 | 7330 | 0.05 | Why? |
| Cytochrome P-450 CYP3A | 1 | 2018 | 88 | 0.05 | Why? |
| Follow-Up Studies | 1 | 2017 | 17020 | 0.05 | Why? |
| Pharmacokinetics | 1 | 2017 | 41 | 0.05 | Why? |
| Hospitals | 1 | 2018 | 11793 | 0.04 | Why? |
| Cross-Cultural Comparison | 1 | 2020 | 338 | 0.04 | Why? |
| Hypertension, Pulmonary | 2 | 2017 | 970 | 0.04 | Why? |
| Infant, Premature, Diseases | 1 | 2018 | 74 | 0.04 | Why? |
| Cohort Studies | 2 | 2021 | 36005 | 0.04 | Why? |
| Pulmonary Valve | 1 | 2017 | 31 | 0.04 | Why? |
| Ventricular Septal Rupture | 1 | 2017 | 41 | 0.04 | Why? |
| Prognosis | 2 | 2018 | 32490 | 0.04 | Why? |
| Erythrocyte Count | 1 | 2017 | 137 | 0.04 | Why? |
| Epidemiologic Methods | 1 | 2020 | 392 | 0.04 | Why? |
| Vascular Resistance | 1 | 2017 | 148 | 0.04 | Why? |
| Adolescent | 2 | 2017 | 86841 | 0.04 | Why? |
| Young Adult | 2 | 2018 | 93724 | 0.04 | Why? |
| APACHE | 1 | 2019 | 682 | 0.04 | Why? |
| Cytokines | 1 | 2018 | 15010 | 0.04 | Why? |
| Calcitonin | 1 | 2018 | 201 | 0.04 | Why? |
| Inflammation | 1 | 2018 | 13255 | 0.04 | Why? |
| Clinical Protocols | 2 | 2017 | 2734 | 0.04 | Why? |
| Biocompatible Materials | 1 | 2017 | 214 | 0.04 | Why? |
| Adrenomedullin | 1 | 2018 | 217 | 0.04 | Why? |
| Incidence | 1 | 2017 | 25622 | 0.04 | Why? |
| Pneumonia, Viral | 2 | 2020 | 243684 | 0.04 | Why? |
| Lactic Acid | 1 | 2018 | 393 | 0.03 | Why? |
| Coronavirus Infections | 2 | 2020 | 253789 | 0.03 | Why? |
| Materials Testing | 1 | 2017 | 380 | 0.03 | Why? |
| Focus Groups | 1 | 2018 | 811 | 0.03 | Why? |
| Nebulizers and Vaporizers | 1 | 2018 | 497 | 0.03 | Why? |
| Protein Precursors | 1 | 2018 | 425 | 0.03 | Why? |
| Single-Blind Method | 1 | 2017 | 1283 | 0.03 | Why? |
| Infusions, Intravenous | 1 | 2017 | 1224 | 0.03 | Why? |
| Particle Size | 1 | 2018 | 1052 | 0.03 | Why? |
| Infant, Premature | 1 | 2018 | 883 | 0.03 | Why? |
| Suction | 1 | 2014 | 297 | 0.03 | Why? |
| Drug Stability | 1 | 2012 | 236 | 0.03 | Why? |
| New Zealand | 1 | 2019 | 2073 | 0.03 | Why? |
| Treatment Failure | 1 | 2018 | 2106 | 0.03 | Why? |
| Drug Administration Schedule | 1 | 2018 | 2324 | 0.03 | Why? |
| Patient Transfer | 1 | 2018 | 898 | 0.03 | Why? |
| Research Design | 2 | 2017 | 5830 | 0.03 | Why? |
| Rats, Wistar | 1 | 2012 | 621 | 0.03 | Why? |
| Pulmonary Artery | 1 | 2017 | 803 | 0.03 | Why? |
| Tomography, X-Ray Computed | 1 | 2017 | 25144 | 0.03 | Why? |
| Ventricular Dysfunction, Right | 1 | 2017 | 639 | 0.03 | Why? |
| Kinetics | 1 | 2018 | 3238 | 0.02 | Why? |
| Exhalation | 1 | 2012 | 441 | 0.02 | Why? |
| Microbial Sensitivity Tests | 1 | 2018 | 2886 | 0.02 | Why? |
| Kaplan-Meier Estimate | 1 | 2018 | 4260 | 0.02 | Why? |
| Evidence-Based Medicine | 1 | 2020 | 3228 | 0.02 | Why? |
| Blood Transfusion | 1 | 2017 | 1399 | 0.02 | Why? |
| Cost-Benefit Analysis | 1 | 2017 | 2259 | 0.02 | Why? |
| Seasons | 1 | 2017 | 4071 | 0.02 | Why? |
| Rats | 1 | 2012 | 2764 | 0.02 | Why? |
| Research | 1 | 2017 | 2115 | 0.02 | Why? |
| Europe | 1 | 2021 | 12702 | 0.02 | Why? |
| Bacterial Infections | 1 | 2018 | 2229 | 0.02 | Why? |
| High-Throughput Screening Assays | 1 | 2012 | 1783 | 0.02 | Why? |
| Aerosols | 1 | 2018 | 5393 | 0.01 | Why? |
| C-Reactive Protein | 1 | 2018 | 7972 | 0.01 | Why? |
| Attitude of Health Personnel | 1 | 2018 | 4741 | 0.01 | Why? |
| Models, Theoretical | 1 | 2018 | 6659 | 0.01 | Why? |
| Comorbidity | 1 | 2021 | 34796 | 0.01 | Why? |
| Infant, Newborn | 1 | 2018 | 23105 | 0.01 | Why? |
| Quality of Life | 1 | 2017 | 9820 | 0.01 | Why? |
| Infant | 1 | 2018 | 30274 | 0.01 | Why? |
| Severity of Illness Index | 1 | 2021 | 48226 | 0.01 | Why? |
| Practice Guidelines as Topic | 1 | 2016 | 15421 | 0.01 | Why? |
| Child | 1 | 2020 | 70012 | 0.01 | Why? |
| Betacoronavirus | 1 | 2020 | 204454 | 0.00 | Why? |